| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/24/2005 | WO2005016132A2 Diagnostics for sars virus |
| 02/24/2005 | WO2005016130A2 Recombinant lubricin molecules and uses thereof |
| 02/24/2005 | WO2005016127A2 Prion-specific peptide reagents |
| 02/24/2005 | WO2005015990A1 New diabetes type 2 animal model |
| 02/24/2005 | WO2005015988A1 Npc1l1 (npc3) and methods of use thereof |
| 02/24/2005 | WO2005003157A3 Interferon variants with improved properties |
| 02/24/2005 | WO2005000872A3 Collagen mimics |
| 02/24/2005 | WO2004113542B1 Methods and means for delaying seed shattering in plants |
| 02/24/2005 | WO2004104031A3 Modified antiviral peptides with increased activity and cell membrane affinity |
| 02/24/2005 | WO2004099247A3 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 02/24/2005 | WO2004093907A3 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents |
| 02/24/2005 | WO2004091436A3 Methods and compositions for treating ocular disease |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2004085664A3 Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use |
| 02/24/2005 | WO2004085634A3 Infectious bursal disease virus mutants and vaccines |
| 02/24/2005 | WO2004083436A3 Novel bt toxin receptors and methods of use |
| 02/24/2005 | WO2004076665A3 Vaccines derived from epithelial cell mucin muc-1 |
| 02/24/2005 | WO2004072099A3 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41 |
| 02/24/2005 | WO2004067723A3 Floral development genes |
| 02/24/2005 | WO2004061082A3 Fanc gene mutations in cancer |
| 02/24/2005 | WO2004058809A3 Novel essential bacterial polypeptides |
| 02/24/2005 | WO2004056386A3 Nucleic acids involved in blood-brain barrier control |
| 02/24/2005 | WO2004055196A3 Method for identifying risk of breast cancer and treatments thereof |
| 02/24/2005 | WO2004052293A3 Recombinant vaccine against flavivirus infection |
| 02/24/2005 | WO2004044165A3 Lipid-associated proteins |
| 02/24/2005 | WO2004042352A3 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 02/24/2005 | WO2004031409A3 Method for diagnosing chronic myeloid leukemia |
| 02/24/2005 | WO2004030636A3 Human papillomavirus polypeptides and immunogenic compositions |
| 02/24/2005 | WO2004027041A3 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2004021871A3 Hcv assay |
| 02/24/2005 | WO2004005530A3 Compositions and methods for treatment and detection of multiple cancers |
| 02/24/2005 | WO2003106650A3 Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 02/24/2005 | WO2003093450A3 Maize clavata3-like polynucleotide sequences and methods of use |
| 02/24/2005 | WO2003093299A3 Insulin-associated peptides with effects on cerebral health |
| 02/24/2005 | WO2003083049A3 Cloning and characterization of g+c-rich promoter binding protein |
| 02/24/2005 | WO2003064616A3 Compounds and methods for inducing growth arrest and apoptosis |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | WO2003008627A3 Phenylthiocarbamide (ptc) taste receptor |
| 02/24/2005 | WO2002074237A8 Compositions and methods for the therapy and diagnosis of kidney cancer |
| 02/24/2005 | US20050044593 Chloroplast transformation of duckweed |
| 02/24/2005 | US20050044592 Plant growth modulation |
| 02/24/2005 | US20050044588 Methods and substances for preventing and treating autoimmune disease |
| 02/24/2005 | US20050044586 Recombinant promoter drives tissue-specific expression of heterologous nucleic acid molecule in floral organ; improved fragrance and color |
| 02/24/2005 | US20050044585 Plants with enhanced levels of nitrogen utilization proteins in their root epidermis and uses thereof |
| 02/24/2005 | US20050044581 Animals and cells containing a mutated alpha2/omega1 gene |
| 02/24/2005 | US20050044578 Rat highly sensitive to carcinogen |
| 02/24/2005 | US20050043530 Seminal vesicle tissue-specific promoters and uses thereof |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043526 Sigma factor A (SIGA) protein for use as tool in expression of operons associated with lysine biosynthesis; ennhancing animal feeds; cosmetics; medicine |
| 02/24/2005 | US20050043520 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/24/2005 | US20050043518 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 02/24/2005 | US20050043513 Nucleotide sequences coding olfactory receptor protein for use in pest control, cosmetics, deodorants and treatment and prevention of disorders associated with loss of smell |
| 02/24/2005 | US20050043512 Human glioma antigen originating in testis |
| 02/24/2005 | US20050043511 G-protein coupled receptor lustr2 and uses thereof |
| 02/24/2005 | US20050043510 Immobilization on matrix; fusion proteins; high throughput assay; kits |
| 02/24/2005 | US20050043508 Synthetic peptide having an ionophoric and antimicrobial activity |
| 02/24/2005 | US20050043361 MitoNEET polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same |
| 02/24/2005 | US20050043265 High affinity RNA ligands of basic fibroblast growth factor |
| 02/24/2005 | US20050043262 Administering antisense oligonucleotide molecule directed to the nucleotide sequence of p21Waf1/Cip1; treating diseases associated with abnormal cell growth and proliferation |
| 02/24/2005 | US20050043261 RNA of ribonucleoprotein U1 snRNP with a modification at the 5' end of its nucleotide sequence, is hybridized in at least one region of the 3' terminal exon of a target mRNA of the gene to be inactivated. |
| 02/24/2005 | US20050043260 cardiomyocyte differentiation from a non-cardiomyocyte cell; cardiac specific polynucleotide selected from Nkx2.5, GATA4, MEF2C, Tbx5, CRIPTO, NODAL, and cardiac myosin heavy chain |
| 02/24/2005 | US20050043254 contacting MT 0039 protein or the transformant expressing the protein with a candidate for screening an agent capable of controlling an activity of the protein |
| 02/24/2005 | US20050043243 Polypeptide for use in treatment of energy balance defects, energy balance involving energy metabolism, nutritional state, lipid storage and the like, food intake and metabolism of carbohydrates and lipids to generate energy |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043238 Exendin formulations for weight reduction |
| 02/24/2005 | US20050043237 Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use |
| 02/24/2005 | US20050043236 Nucleic acids; fusion proteins; binding to endothelial growth factor; fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 02/24/2005 | US20050043235 Use of VEGF-C or VEGF-D in reconstructive surgery |
| 02/24/2005 | US20050043234 Novel FGF homologs |
| 02/24/2005 | US20050043232 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 02/24/2005 | US20050043229 Amino acid sequences of human secreted peptides and proteins that are related to the epidermal growth factor protein subfamily, as well as allelic variants and other mammalian orthologs thereof; for use in human therapeutics and diagnostics |
| 02/24/2005 | US20050043228 Glp-1 formulations with protracted time action |
| 02/24/2005 | US20050043226 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 02/24/2005 | US20050043219 Derivatized oligonucleotides having improved uptake and other properties |
| 02/24/2005 | US20050043218 Gene therapy for accelerating the post-chemotherapy peripheral blood cell recovery; removal of hematopoietic cells, transfection, ex vivo contact with an amino acid sequence from a chain of hemoglobin, transplanting the cells back into the patient |
| 02/24/2005 | US20050043198 A related nucleic acid, expression vector, host cell, and protein, the protein having a common epitope with the protease; the protease acts as an unspecific endopeptidase; cleaners also contain an amylase, cellulase, hemicellulase, oxidoreductase, or lipase; cosmetics |
| 02/24/2005 | US20050043096 Biometric broadband gaming system and method |
| 02/24/2005 | US20050042755 Bacterium for use as vehicle for gene transport and transfer to preferential organs or tissues; tissue engineering and targeted somatic transgenesis |
| 02/24/2005 | US20050042754 Induction of the formation of insulin-producing cells via gene transfer of pancreatic beta-cell-associated transcriptional factor |
| 02/24/2005 | US20050042747 Immunoglobulin mixture which prevents and/or reduces viral associated with cells; immunotherapeutic and g-protein binding |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042732 Zinc finger-based drug-dependent gene regulation system |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042730 Gene screening method using nuclear receptor |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042728 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 02/24/2005 | US20050042726 Nucleotide sequences coding functional fragment of viomycin gene cluster for use in treatment of tuberculosis |
| 02/24/2005 | US20050042725 Green fluorescent protein from Ptilosarcus gurneyi; use as probe; humanized Ptilosarcus gurneyi green fluorescent protein is useful as a fluorescent tag for monitoring the activities of its fusion partners using imaging |
| 02/24/2005 | US20050042724 Sodium-dependent phosphate cotransporter (NAPTR) for use tool in identifying modulators for treatment and prevention of cell proliferative, nervous system and cardiovascular disorders |
| 02/24/2005 | US20050042723 Novel calcium channel |
| 02/24/2005 | US20050042720 Modified g-protein for use as tool in identifying modulator for treatment of cell proliferative disorders; mimetics; high throughput assay |
| 02/24/2005 | US20050042719 Adipocyte complement related protein homolog zacrp5 |
| 02/24/2005 | US20050042717 Scorpion toxins |
| 02/24/2005 | US20050042715 Preparing transgenic canola seeds with improved expression of genes associated with oil seed protein production; recovering plant seed protein |
| 02/24/2005 | US20050042714 Glycoconjugates of sialic acid derivates, methods for their production and use thereof |
| 02/24/2005 | US20050042704 Entrapped binding protein as biosensors |
| 02/24/2005 | US20050042700 Compositions and methods for monitoring breast cancer treatment |
| 02/24/2005 | US20050042699 Cardiotrophin-1 compositions and methods for the treatment of tumor |